Literature DB >> 19148573

Neuropsychological assessment in myasthenia gravis.

Emilia J Sitek1, Małgorzata M Bilińska, Dariusz Wieczorek, Walenty M Nyka.   

Abstract

Neuropsychological studies in myasthenia gravis (MG) were undertaken to prove the central nervous involvement. However, they still produce contradictory results. In the present study, a battery of cognitive measures was administered to examine global cognitive functioning, verbal learning, attention, executive function and motor performance. Analysis of partial scores in verbal learning and response fluency trials did not reveal fatigue effect in MG patients. It was shown that in tasks requiring motor, and particularly oculomotor, involvement, the muscle fatigue could account for the deficits observed. Thus, impaired performance on some cognitive measures in MG should be interpreted as an effect of muscle fatigability rather than central nervous system involvement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148573     DOI: 10.1007/s10072-008-0001-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

Review 1.  What have we learned about cognition in myasthenia gravis?: a review of methods and results.

Authors:  R H Paul; R A Cohen; T Zawacki; J M Gilchrist; M S Aloia
Journal:  Neurosci Biobehav Rev       Date:  2001-01       Impact factor: 8.989

2.  Cognitive dysfunction in myasthenia gravis.

Authors:  Y Iwasaki; M Kinoshita; K Ikeda; K Takamiya; T Shiojima
Journal:  Int J Neurosci       Date:  1990-09       Impact factor: 2.292

3.  Brain stem auditory evoked potentials reflect central nervous system involvement in myasthenia gravis.

Authors:  R Jech; E Růzicka
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

4.  [Psychological problems in the treatment of myasthenia patients].

Authors:  H G Mertens; J Lützenkirchen; G Hertel
Journal:  Nervenarzt       Date:  1976-08       Impact factor: 1.214

5.  Electroencephalographic findings in myasthenia gravis. 180 EEG recordings of 109 patients.

Authors:  E Hokkanen; E Toivakka
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

6.  Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis.

Authors:  A K Lefvert; R Pirskanen
Journal:  Lancet       Date:  1977-08-13       Impact factor: 79.321

7.  Sleep apnea and cognitive dysfunction in myasthenia gravis.

Authors:  R Stepansky; G Weber; J Zeitlhofer
Journal:  Acta Med Austriaca       Date:  1997

8.  Ratings of subjective mental fatigue relate to cognitive performance in patients with myasthenia gravis.

Authors:  Robert H Paul; Ronald A Cohen; James M Gilchrist
Journal:  J Clin Neurosci       Date:  2002-05       Impact factor: 1.961

9.  A reliability study of impairment and disability scales for myasthenia gravis patients.

Authors:  Alfredo Romani; Giovanni Piccolo; Roberto Bergamaschi; Maurizio Versino; Vittorio Cosi
Journal:  Funct Neurol       Date:  2002 Jul-Sep

10.  Acquired blepharoptosis.

Authors:  H J Oosterhuis
Journal:  Clin Neurol Neurosurg       Date:  1996-02       Impact factor: 1.876

View more
  7 in total

1.  Psychosocial aspects in myasthenic patients treated by plasmapheresis.

Authors:  Yu-Tai Chen; Yuanmay Chang; Hou-Chang Chiu; Jiann-Horng Yeh
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

2.  Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.

Authors:  Qian-Sheng Yu; Harold W Holloway; Weiming Luo; Debomoy K Lahiri; Arnold Brossi; Nigel H Greig
Journal:  Bioorg Med Chem       Date:  2010-05-12       Impact factor: 3.641

3.  Fatigue in patients with myasthenia gravis.

Authors:  T M Alekseeva; Y V Gavrilov; O A Kreis; P O Valko; K P Weber; Y Valko
Journal:  J Neurol       Date:  2018-08-11       Impact factor: 4.849

Review 4.  Association between myasthenia gravis and cognitive function: A systematic review and meta-analysis.

Authors:  Zhifeng Mao; Junjie Yin; Zhengqi Lu; Xueqiang Hu
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

5.  Prospective study of stress, depression and personality in myasthenia gravis relapses.

Authors:  Anca Bogdan; Carolina Barnett; Abdulrahman Ali; Mohammed AlQwaifly; Alon Abraham; Shabber Mannan; Eduardo Ng; Vera Bril
Journal:  BMC Neurol       Date:  2020-06-29       Impact factor: 2.474

6.  Prevalence and Associated Factors of Depressive Symptoms in Patients with Myasthenia Gravis: A Cross-Sectional Study of Two Tertiary Hospitals in Riyadh, Saudi Arabia.

Authors:  Mohammed H Alanazy
Journal:  Behav Neurol       Date:  2019-09-15       Impact factor: 3.342

7.  Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.

Authors:  Antonia Kaltsatou; Dimitris Fotiou; Dimitris Tsiptsios; Anastasios Orologas
Journal:  BBA Clin       Date:  2015-04-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.